Directly observed therapy.
Chaulk
C P
CP
Iseman
M D
MD
D000995:Antitubercular Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004358:Drug Therapy / Q000191:economics / Q000592:standards*; D006801:Humans; D010349:Patient Compliance; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents